Support the MS Alliance of Virginia: Empowering Lives, Building Community
The MS Alliance of Virginia is a 100% volunteer-run 501(c)(3) nonprofit, dedicated to empowering individuals impacted by Multiple Sclerosis. We believe in focusing on what we can do, fostering a vibrant community through engaging events, vital support, and uplifting experiences.
We bring people together through:
- Educational Events: Informative sessions with expert speakers.
- Local Support Groups: Creating connections and shared understanding – including rural and underserved areas of SW Virginia.
- Signature Overnight Events: Including our festive Holiday Gala, impactful MS Awareness Month event, and a much-needed Respite Weekend offered at a significantly reduced rate for qualifying individuals.

Because we have no paid staff, every dollar you donate directly supports our programs and events, helping us create memorable experiences and provide crucial resources for our community.
Your contribution, no matter the size, makes a real difference. It helps us continue to offer:
- Opportunities for connection and fun
- Valuable educational resources
- A strong, supportive community for those living with MS
Please consider making a donation today. Join us in building a community where joy, education, and connection thrive.
Ready to make an impact?

Recently, Mr. Joe Huntsman, the new CEO and owner of the Roanoke Area MS Center and Blue Ridge Neurology in Christiansburg was kind enough to answer some of the more common questions we have been hearing at the MS Alliance of Virginia regarding Dr. Jill Cramer’s retirement and subsequent purchase of her practice by BrookWell Infusion. Read below to hear what he has to say…
MSAV – When will the new neurologists and other providers be available to see patients, and how can appointments be scheduled?
Mr. Huntsman – The new neurology full team will begin to see patients in September and appointments are already being scheduled. However, we are providing infusions for several insurance plans this summer (already).
MSAV – What is the procedure for patients with existing referrals or those who have previously received care at the MS Center to return for appointments?
Mr. Huntsman – If a patient has received care at the Roanoke MS Center in Salem or Blue Ridge Associates in Neurology in Christiansburg in the past, we do not need a new referral unless insurance requires it. Simply a call to schedule an appointment is all that is needed. We truly hope that all patients return, and it would be an honor to serve each of them…….. Read more by clicking HERE!


Monte Rosa Plans to Begin Phase 1 Trial of MRT-6160 in Mid-2024
Monte Rosa Therapeutics is planning to initiate a Phase 1 clinical trial to test MRT-6160, its investigational therapy for multiple sclerosis (MS) and other autoimmune diseases, by mid-2024. The trial will follow the submission of an an investigational new drug (IND)...
Love and MS
Let’s be honest, it’s very easy to admit that we love our significant others, but we may not always like them. That is naturally going to happen when you literally spend the rest of your life with someone. When the person you love has MS, things may not always make...
Why Get a Proclamation?
One way to engage your elected and public officials while also raising public awareness of Multiple Sclerosis is to obtain a 'March is MS Awareness Month' proclamation from your city or state. Proclamations are formal declarations issued by a person of authority and...
MS Activity Not Likely to Be Affected by Dairy or Gluten Foods, Study Finds
An analysis of data covering nearly 200 people with multiple sclerosis (MS) found no association between dairy or gluten consumption and MS disease activity. While some specific diets for MS tend to restrict gluten and/or dairy, this study found that people who ate...
Dosing Begins in Phase 2a Trial of Foralumab Nasal Spray for SPMS
Tiziana Life Sciences has dosed the first patient in a Phase 2a clinical trial testing its foralumab nasal spray in people with nonactive secondary progressive multiple sclerosis (SPMS). The trial will include about 54 participants, enrolled across six clinical sites....